Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Ocana

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
European Urology|June 3, 2014
Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysisFrancisco E Vera-Badillo, Arnoud J Templeton, Ignacio Duran, et al.
Computers in Biology and Medicine|October 19, 2025
DrugAppy - An end-to-end deep learning framework for computational drug discoveryElisa Poyatos-Racionero, Lucía Paniagua-Herranz, Cristian Privat, et al.
Plos One|April 30, 2014
Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysisAlberto Ocana, Francisco Vera-Badillo, Mustafa Al-Mubarak, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2016
Honorary and ghost authorship in reports of randomised clinical trials in oncologyFrancisco Emilio Vera-Badillo, Marc Napoleone, Monika K Krzyzanowska, et al.
Journal of Chemical Information and Modeling|April 18, 2026
Comparative Assessment of Free Energy Computational Methods for Revealing the Interactions Driving PARP1 Selective InhibitionAlejandro Feito, Natàlia DeMoya-Valenzuela, Cristian Privat, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2016
Bias in reporting of randomised clinical trials in oncologyFrancisco E Vera-Badillo, Marc Napoleone, Monika K Krzyzanowska, et al.
Plos One|July 11, 2015
Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast CancerMelissa Chan, Martin C Chang, Rosa González, et al.
Investigational New Drugs|September 13, 2014
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicinIrene Brana, Alberto Ocana, Eric X Chen, et al.
Journal of the National Cancer Institute|November 26, 2013
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysisFrancisco E Vera-Badillo, Arnoud J Templeton, Paulo de Gouveia, et al.
Journal of Hematology & Oncology|December 13, 2023
Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learnedAlfonso López de Sá, Cristina Díaz-Tejeiro, Elisa Poyatos-Racionero, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
European Urology|June 3, 2014
Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysisFrancisco E Vera-Badillo, Arnoud J Templeton, Ignacio Duran, et al.
Computers in Biology and Medicine|October 19, 2025
DrugAppy - An end-to-end deep learning framework for computational drug discoveryElisa Poyatos-Racionero, Lucía Paniagua-Herranz, Cristian Privat, et al.
Plos One|April 30, 2014
Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysisAlberto Ocana, Francisco Vera-Badillo, Mustafa Al-Mubarak, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2016
Honorary and ghost authorship in reports of randomised clinical trials in oncologyFrancisco Emilio Vera-Badillo, Marc Napoleone, Monika K Krzyzanowska, et al.
Journal of Chemical Information and Modeling|April 18, 2026
Comparative Assessment of Free Energy Computational Methods for Revealing the Interactions Driving PARP1 Selective InhibitionAlejandro Feito, Natàlia DeMoya-Valenzuela, Cristian Privat, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2016
Bias in reporting of randomised clinical trials in oncologyFrancisco E Vera-Badillo, Marc Napoleone, Monika K Krzyzanowska, et al.
Plos One|July 11, 2015
Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast CancerMelissa Chan, Martin C Chang, Rosa González, et al.
Investigational New Drugs|September 13, 2014
A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicinIrene Brana, Alberto Ocana, Eric X Chen, et al.
Journal of the National Cancer Institute|November 26, 2013
Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysisFrancisco E Vera-Badillo, Arnoud J Templeton, Paulo de Gouveia, et al.
Journal of Hematology & Oncology|December 13, 2023
Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learnedAlfonso López de Sá, Cristina Díaz-Tejeiro, Elisa Poyatos-Racionero, et al.
Pageof 10